Cargando…
Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
The carbapenem breakpoints set by different organizations for Acinetobacter are discordant, but supporting clinical data are lacking. This study aimed to provide the first clinical outcome data to support the carbapenem breakpoints for Acinetobacter baumannii (Ab) group in patients with bacteremia....
Autores principales: | Lee, Yi-Tzu, Chiang, Mei-Chun, Kuo, Shu-Chen, Wang, Yung-Chih, Lee, I-Hsin, Chen, Te-Li, Yang, Ya-Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028070/ https://www.ncbi.nlm.nih.gov/pubmed/27644087 http://dx.doi.org/10.1371/journal.pone.0163271 |
Ejemplares similares
-
Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013) -
Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020) -
Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
por: Chiang, Tsung-Ta, et al.
Publicado: (2022) -
Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
por: Chiang, Ming-Hsien, et al.
Publicado: (2020) -
1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)